Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis

Abstract Tumor necrosis factor is a major pro-inflammatory cytokine which triggers various physiological consequences by binding to and trimerizing its receptors, and has been the single most sought-after drug target for intervening autoimmune diseases such as rheumatoid arthritis and psoriasis. How...

Full description

Bibliographic Details
Main Authors: Xiaofang Cui, Linmo Chang, Youwei Li, Qianrui Lv, Fei Wang, Yaxian Lin, Weiyang Li, Jonathan D. Meade, Jamie C. Walden, Peng Liang
Format: Article
Language:English
Published: Nature Portfolio 2018-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-018-25652-w
_version_ 1818425281603436544
author Xiaofang Cui
Linmo Chang
Youwei Li
Qianrui Lv
Fei Wang
Yaxian Lin
Weiyang Li
Jonathan D. Meade
Jamie C. Walden
Peng Liang
author_facet Xiaofang Cui
Linmo Chang
Youwei Li
Qianrui Lv
Fei Wang
Yaxian Lin
Weiyang Li
Jonathan D. Meade
Jamie C. Walden
Peng Liang
author_sort Xiaofang Cui
collection DOAJ
description Abstract Tumor necrosis factor is a major pro-inflammatory cytokine which triggers various physiological consequences by binding to and trimerizing its receptors, and has been the single most sought-after drug target for intervening autoimmune diseases such as rheumatoid arthritis and psoriasis. However, current TNF-α blockers, including soluble receptor-Fc fusion and therapeutic antibodies, are all dimeric in structure, whereas their target TNF-α itself is homotrimeric in nature. Here we describe the development of a trivalent soluble TNF receptor and show that it is a more potent than the dimeric TNF receptor decoys in inhibiting TNF-α signaling both in vitro and in vivo. The process involves gene fusion between a soluble receptor TNFRII with a ligand binding domain and a trimerization tag from the C-propeptide of human collagen (Trimer-Tag), which is capable of self-assembly into a covalently linked trimer. We show that the homotrimeric soluble TNF receptor (TNFRII-Trimer) produced with such method is more potent in ligand binding kinetics and cell based bioassays, as well as more efficacious in attenuating collagen-induced arthritis (CIA) in a mouse model than its dimeric TNFRII-Fc counterpart. Thus, this work demonstrates the proof of concept of Trimer-Tag and provides a new platform for rational designs of next generation biologic drugs.
first_indexed 2024-12-14T14:11:27Z
format Article
id doaj.art-cc6ab514259e46329891bf7dc1a71817
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T14:11:27Z
publishDate 2018-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-cc6ab514259e46329891bf7dc1a718172022-12-21T22:58:17ZengNature PortfolioScientific Reports2045-23222018-05-018111110.1038/s41598-018-25652-wTrivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritisXiaofang Cui0Linmo Chang1Youwei Li2Qianrui Lv3Fei Wang4Yaxian Lin5Weiyang Li6Jonathan D. Meade7Jamie C. Walden8Peng Liang9Department of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan UniversityDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan UniversityDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan UniversityDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan UniversityDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan UniversityDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan UniversityJining Medical UniversityGenHunter CorporationGenHunter CorporationDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan UniversityAbstract Tumor necrosis factor is a major pro-inflammatory cytokine which triggers various physiological consequences by binding to and trimerizing its receptors, and has been the single most sought-after drug target for intervening autoimmune diseases such as rheumatoid arthritis and psoriasis. However, current TNF-α blockers, including soluble receptor-Fc fusion and therapeutic antibodies, are all dimeric in structure, whereas their target TNF-α itself is homotrimeric in nature. Here we describe the development of a trivalent soluble TNF receptor and show that it is a more potent than the dimeric TNF receptor decoys in inhibiting TNF-α signaling both in vitro and in vivo. The process involves gene fusion between a soluble receptor TNFRII with a ligand binding domain and a trimerization tag from the C-propeptide of human collagen (Trimer-Tag), which is capable of self-assembly into a covalently linked trimer. We show that the homotrimeric soluble TNF receptor (TNFRII-Trimer) produced with such method is more potent in ligand binding kinetics and cell based bioassays, as well as more efficacious in attenuating collagen-induced arthritis (CIA) in a mouse model than its dimeric TNFRII-Fc counterpart. Thus, this work demonstrates the proof of concept of Trimer-Tag and provides a new platform for rational designs of next generation biologic drugs.https://doi.org/10.1038/s41598-018-25652-w
spellingShingle Xiaofang Cui
Linmo Chang
Youwei Li
Qianrui Lv
Fei Wang
Yaxian Lin
Weiyang Li
Jonathan D. Meade
Jamie C. Walden
Peng Liang
Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
Scientific Reports
title Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
title_full Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
title_fullStr Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
title_full_unstemmed Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
title_short Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
title_sort trivalent soluble tnf receptor a potent tnf α antagonist for the treatment collagen induced arthritis
url https://doi.org/10.1038/s41598-018-25652-w
work_keys_str_mv AT xiaofangcui trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT linmochang trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT youweili trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT qianruilv trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT feiwang trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT yaxianlin trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT weiyangli trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT jonathandmeade trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT jamiecwalden trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis
AT pengliang trivalentsolubletnfreceptorapotenttnfaantagonistforthetreatmentcollageninducedarthritis